secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardion Health Sciences, Inc. (—)
CIK:        0001642375
Form:       8-K
Filed at:   2024-09-23T23:59:59+00:00
Accession:  0001493152-24-037760
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Guardion Health Sciences terminates CEO Jan Hall; effective Oct 17, 2024
------------------------------------------------------------------------

- Janet Hall terminated as President and CEO; remains employee through Oct 17, 2024.
- Severance of ~$400,000 plus $300,000 transaction bonus from Viactiv sale.
- Company expects to name interim CEO before Oct 17, 2024.
- No permanent replacement announced yet; search underway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224037760/0001493152-24-037760-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224037760/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-037760

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer